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Abstract  
The primary objective of this research study was to assess whether there exist gender-based mean differences in 
the recovery speed from COVID-19 infection among case-patients in Mpumalanga province. A sample of 5723 
case-patients in the province was used. Using the date at which the result confirming positivity for each case was 
received and the date at which discharge occurred, the date function in Excel was used to compute the speed of 
recovery, measured by the number of days. The speed of recovery from infection was computed as the number 
of days from first positive to first negative SARSCoV-2 PCR test result. Data was processed in Excel and 
Statistical Package for Social Sciences (SPSS) software prior to conducting statistical data analysis. Results 
show that female case patients in each age group were larger than their counterpart male case patients, while 
Nkangala district had the largest numbers of case patients across all age groups. The average recovery speed for 
male case patients was 16.89 days, with a standard deviation of ±7.23 days, while the mean recovery speed for 
female case patients was marginally lower at 16.87 days, but with a marginally higher standard deviation of 
±7.47 days. The Levene’s test for equality of variance statistics (F-statistic = 0.686; p-value > 0.05) reveals no 
evidence of variability in the recovery speed (days) between male and female case patients. 
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1. Introduction 
COVID-19 affects humans in all gender groups, and also affects other health conditions. Until a vaccine is found 
and approved, the pandemic will remain as a grave global health hazard. SARS-CoV-2 has been confirmed as 
the causative virus of COVID-19, which has rapidly become a global pandemic continuing to spread across 
countries in the world. Since COVID-19 is a new disease, there is much limited information regarding risk 
factors for severe disease. In some cases, people who get COVID-19 can become seriously ill and develop 
difficulties in breathing, whereas severe complications can lead to death. Populations with underlying medical 
conditions such as those who are immunocompromised like serious heart problems and chronic lung disease are 
more likely to develop serious illnesses. As more data become available, additional risk factors of severe 
COVID-19 may be identified. Since its outbreak worldwide, the COVID-19 pandemic has shown relatively 
similar proportions of cases among people in all gender groups (National Institute of Communicable Diseases, 
2020).  
 
Most of case-patients initially identified were dealers and vendors at a seafood, poultry and live wildlife market 
in China (WHO, 2020). In line with the global statistics, people who are most at higher risk are the elderly, 
individuals with co-morbidities and healthcare workers (Department of Health, 2020). The spread of the disease 
is believed to happen primarily via respiratory droplets produced when an infected person coughs or sneezes, 
similar to how influenza and other respiratory pathogens spread. Thus, the majority of cases have occurred in 
people with close physical contact to patient cases and healthcare workers proving healthcare to patients with 
COVID-19 (National Institute of Communicable Diseases, 2020). The treatment of COVID-19 is mainly 
supportive in form provision of oxygen for patients with some shortness of breath, coupled with other associated 
symptoms likes fever, dry cough and sore throat, Human antibiotics do not treat viral infections, but such 
antibiotics may be required if a bacterial secondary infection develops.  
 
1.1. Research Objective  
 To assess whether there exist gender-based mean differences in the recovery speed among COVID-19 
case-patients in Mpumalanga province.   
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1.2. Research Question  
 Are there gender-based mean differences in the recovery speed among COVID-19 case-patients in 
Mpumalanga province? 
 
1.3. Research Hypothesis   
 There are no gender-based mean differences in the recovery speed among the COVID-19 among case-
patients in Mpumalanga province.    
 
1.4. Significance of the Study  
The results from this analysis on gender-based mean differences in the recovery speed from COVID-19 infection 
among case-patients in Mpumalanga are expected to provide insights to both health practitioners and policy 
makers on health interventions that can be pursued to curb the spread of the disease among cases based on 
gender group. In terms of monitoring, findings can provide insights on the ways in which infection prevention 
and control can be directed to gender-group based case-patients. 
 
2. Materials and Methods  
 
2.1. Design 
A descriptive research design was used in the analytical study. The categorical factor was the gender group of 
case patients, while the dependent variable was the “recovery speed measured in number of days”. 
 
2.2. Population and Sample 
The population for the study was case patients who got infected and first tested positive from a first SARS CoV-
2 PCR test and later tested negative to SARS-CoV-2 PCR test after a certain period. The sample consists of 5 
723 clinically confirmed recovered cases as at 21 July 2020.        
 
2.3. Data 
The secondary dataset used in the analysis was obtained from Mpumalanga Department of Health (MDoH). Data 
cleaning and processing was initially conducted in Excel and Statistical Package for Social Sciences (SPSS) 
prior to conducting statistical analysis. The variable “recovery speed (days)” was calculated by inserting the date 
at which the result confirming positivity was received and the date discharge occurred into the DATEDIF() 
function in Excel. Therefore, the time from infection to recovery is measured as the number of days from first 
positive to first negative SARSCoV-2 PCR test result.  
 
2.5. Statistical Technique 
The independent samples t-test was used to assess whether there exists a statistically significant difference 
between means in the recovery speed (dependent variable) across gender groups (independent categorical 


















        
                                                                                                              (1) 
where (N1 + N2) – 2 is the degree of freedom (df), 1x is the mean recovery speed (days) of the first gender group 
(male) and 2x  is the mean recovery speed (days) of the second gender group (female), 21S is the standard 
deviation in the mean recovery speed of male case patients and 22S  is the standard deviation in the mean 
recovery speed of female case patients, while 1N  is the sample size of male case patients and 2N  is the sample 
size of female case patients.  
 
3. Results and Analysis  
 
The frequencies and descriptive statistics are presented in Figures 1 and 2 and Tables 1 and 2 below.  
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Figure 1: Distribution of cases per age group by gender  
 
 
Figure 1 shows that the female case patients in each age group were larger than their counterpart male case 
patients, with exception of the 0-9 years age group in which there were 87 female case patients relative to 105 
male case patients. Middle age groups 30-39 years and 40-49 years case patients in all gender groups accounted 
for the largest numbers of COVID-19 case patients in the province.       
 
Figure 2: Distribution of cases per age group by district  
 
 
The frequencies presented in Figure 2 show that Nkangala district had the largest numbers of case patients in all 
age groups, except the 60-69 years in which Gert Sibande had 116 case patients while Nkangala had 115 case 
patients, and 80+ years age groups in which Gert Sibande had 20 case patients while Nkangala had 16 cases. 
Ehlanzeni district generally had the lowest numbers of case patients across all age groups.    
  
Table 1: Gender distribution frequencies  
 Frequency Percent 
Missing 
Male 2734 47.8 
Female 2989 52.2 
Total 5723 100.0 
 
Table 1 gender distribution frequencies indicate that female case patients accounted for the bulk 52% of the total 
case patients, while the remaining 48% were male case patients.    
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Table 2: Descriptive statistics  
 Gender N Mean (std dev) Std. Error Mean 
Recovery speed (days) 
Male 2734 16.89 ±7.23 .138 
Female 2989 16.87 ±7.47 .137 
 
Table 2 descriptive statistics show that the average recovery speed for male case patients was 16.89 days, with a 
standard deviation of ±7.23 days, while the mean recovery speed for female case patients was marginally lower 
at 16.87 days, but with a marginally higher standard deviation of ±7.47 days. Results of the average differences 
in the recovery speed between the gender groups are presented in Table 3 below.  
 
Table 3: Independent samples test 
 Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
























  .090 5702.42 .929 .017 .194 -.364 .398 
 
The Levene’s test for equality of variance statistics (F-statistic = 0.686; p-value > 0.05) reveals no evidence of 
variability in the recovery speed (days) between male and female case patients. The mean differences are not 
statistically significantly different (p = 0.408), hence the null hypothesis of equal variances could not be rejected. 
Therefore, results of the Equal variances not assumed should not be used, whose t-statistic = 0.090 and a mean 
difference = 0.017 calculated by subtracting the mean of the second group (female case patients) from the mean 
of the first group (male case patients). The computed mean difference equal to 0.017 lies within the computed 
confidence interval of the difference.  
 
4. Conclusion and Recommendations 
This research study found no evidence of statistically significant differences in the average recovery speed (days) 
from COVID-19infection between male and female case patients. The findings imply that provision of clinical 
and health-related interventions aimed at curbing the spread of the COVID-19 disease should not be 
differentiated based on gender since the average recovery speed among case-patients in all gender groups is not 
significantly different. ages. Concurrently, follow-ups on recovery cases should be conducted in a standardised 
manner as well, predominantly with close monitoring on case-patients who might have comorbidities and 
chronic health conditions.    
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